by Oscar Jofre | Feb 23, 2022 | Capital Markets, KoreConX, KorePartner, News Releases
Experts in the life sciences sector will teach investors how to use Regulation A+ for successful capital raising NEW YORK, February 23, 2022 – KoreConX is thrilled to announce its participation at LSI Emerging Medtech Summit – USA 2022. This event...
by Oscar Jofre | Feb 17, 2022 | Capital Markets, Capital Raising
Manny Villafaña has a long track record of innovation in the medtech space, delivering solutions to improve cardiac care and surgical procedures. In his latest venture, Manny is creating a product that will change the way cardiac bypass surgeries are performed,...
by Oscar Jofre | Feb 8, 2022 | Capital Markets, Capital Raising, KoreConX, News Releases
‘Father of the JOBS Act,’ Mr. Weild will join KoreConX to address a keynote on how Medtech is the new frontier to a successful capital raising NEW YORK, February 8, 2022 – KoreConX and its partner, Life Science Intelligence, are bringing together top...
by Oscar Jofre | Feb 7, 2022 | Capital Markets, Capital Raising, Regulation, SEC
It is essential to be familiar with the different regulations that govern how companies can raise capital in today’s business world. One important rule is Regulation S. This article will give you a basic overview of Regulation S, how it affects businesses, and...
by Oscar Jofre | Feb 2, 2022 | Capital Markets, Capital Raising
If your company is looking to raise funding, you’ve probably considered many options for doing so. Since the SEC introduced the outlines for Regulation A+ in the JOBS Act in 2012 and its subsequent amendments, companies are able to raise amounts up to $75...
by Oscar Jofre | Jan 26, 2022 | Capital Markets, Capital Raising, KoreConX, KorePartner, News Releases, Regulation
Medtech and Life Sciences main event will be held next March in California. KoreConX is one of the supporting sponsors. NEW YORK, January 26, 2022 – KoreConX is pleased to announce its partnership with LSI Emerging Medtech Summit 2022, which will be held March...
